Skip to main content
. Author manuscript; available in PMC: 2013 Feb 11.
Published in final edited form as: Antiviral Res. 2010 May 7;87(2):195–203. doi: 10.1016/j.antiviral.2010.04.013

Figure 4.

Figure 4

Survival of CD-1 mice treated by subcutaneous CLDC administration at the back of the neck at the same time as infection, or 24h post WEEV-McMillan infection delivered by injection at the inner thigh.